SCHEMBL25897351

SCHEMBL25897351

CC1Oc2c(Br)cccc2-c2n[nH]cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30703392 1.00 — —
SCHEMBL25897346 0.73 DRD4 (0.33) —
SCHEMBL25429843 0.71 ADRA2A (0.37) —
SCHEMBL30703405 0.71 ADRA2A (0.37) —
SCHEMBL25897342 0.68 HIF1A (0.35) —
SCHEMBL29766636 0.68 HIF1A (0.35) —
SCHEMBL11622939 0.62 DCUN1D1 (0.41) —
SCHEMBL25897386 0.60 PBRM1 (0.30) —
SCHEMBL31110713 0.59 NFKB1 (0.31) —
SCHEMBL31110769 0.59 PBRM1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242546-A1 SUBSTITUTED PYRIDINES, PYRIDAZINES, PYRIMIDINES, AND 1,2,4-TRIAZINES AS TYK2 INHIBITORS SUDO BIOSCIENCES LIMITED (GB) 2023-08-03 — — US disclosed
US-20230242546-A1 SUBSTITUTED PYRIDINES, PYRIDAZINES, PYRIMIDINES, AND 1,2,4-TRIAZINES AS TYK2 INHIBITORS SUDO BIOSCIENCES LIMITED (GB) 2023-08-03 — — US disclosed
Send feedback